Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167992488> ?p ?o ?g. }
- W3167992488 abstract "Hepatic fibrosis represents an important event in the progression of chronic liver injury to cirrhosis, and is characterized by excessive extracellular matrix proteins aggregation. Early fibrosis can be reversed by inhibiting hepatocyte injury, inflammation, or hepatic stellate cells activation, so the development of antifibrotic drugs is important to reduce the incidence of hepatic cirrhosis or even hepatic carcinoma. Here we demonstrate that Schisandrol B (SolB), one of the major active constituents of traditional hepato-protective Chinese medicine, Schisandra sphenanthera, significantly protects against hepatocyte injury, while Wedelolactone (WeD) suppresses the TGF-β1/Smads signaling pathway in hepatic stellate cells (HSCs) and inflammation, the combination of the two reverses hepatic fibrosis in mice and the inhibitory effect of the combination on hepatic fibrosis is superior to that of SolB or WeD treatment alone. Combined pharmacotherapy represents a promising strategy for the prevention and treatment of liver fibrosis." @default.
- W3167992488 created "2021-06-22" @default.
- W3167992488 creator A5004190418 @default.
- W3167992488 creator A5007362555 @default.
- W3167992488 creator A5018256092 @default.
- W3167992488 creator A5019002683 @default.
- W3167992488 creator A5028564856 @default.
- W3167992488 creator A5029231785 @default.
- W3167992488 creator A5033097552 @default.
- W3167992488 creator A5045423783 @default.
- W3167992488 creator A5054977436 @default.
- W3167992488 creator A5069771802 @default.
- W3167992488 creator A5074160086 @default.
- W3167992488 creator A5077142060 @default.
- W3167992488 creator A5079563573 @default.
- W3167992488 creator A5079974739 @default.
- W3167992488 creator A5088563107 @default.
- W3167992488 creator A5089792184 @default.
- W3167992488 date "2021-06-03" @default.
- W3167992488 modified "2023-10-01" @default.
- W3167992488 title "The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice" @default.
- W3167992488 cites W1016707613 @default.
- W3167992488 cites W1593855885 @default.
- W3167992488 cites W1829520216 @default.
- W3167992488 cites W1977076453 @default.
- W3167992488 cites W1981262534 @default.
- W3167992488 cites W1990937647 @default.
- W3167992488 cites W2000369852 @default.
- W3167992488 cites W2000463136 @default.
- W3167992488 cites W2006111363 @default.
- W3167992488 cites W2010723255 @default.
- W3167992488 cites W2015146412 @default.
- W3167992488 cites W2016085979 @default.
- W3167992488 cites W2016180965 @default.
- W3167992488 cites W2017961355 @default.
- W3167992488 cites W2018251493 @default.
- W3167992488 cites W2018971514 @default.
- W3167992488 cites W2038394904 @default.
- W3167992488 cites W2042494320 @default.
- W3167992488 cites W2045142779 @default.
- W3167992488 cites W2056565128 @default.
- W3167992488 cites W2084208973 @default.
- W3167992488 cites W2089149502 @default.
- W3167992488 cites W2097059462 @default.
- W3167992488 cites W2129664272 @default.
- W3167992488 cites W2138024058 @default.
- W3167992488 cites W2142225943 @default.
- W3167992488 cites W2165184001 @default.
- W3167992488 cites W2171925512 @default.
- W3167992488 cites W2182271449 @default.
- W3167992488 cites W2194692872 @default.
- W3167992488 cites W2271776986 @default.
- W3167992488 cites W2283663091 @default.
- W3167992488 cites W2327210647 @default.
- W3167992488 cites W2340778896 @default.
- W3167992488 cites W2580021799 @default.
- W3167992488 cites W2736649503 @default.
- W3167992488 cites W2738000380 @default.
- W3167992488 cites W2749828448 @default.
- W3167992488 cites W2751963599 @default.
- W3167992488 cites W2760098333 @default.
- W3167992488 cites W2765309754 @default.
- W3167992488 cites W2776012678 @default.
- W3167992488 cites W2782460017 @default.
- W3167992488 cites W2794423958 @default.
- W3167992488 cites W2796699845 @default.
- W3167992488 cites W2800050447 @default.
- W3167992488 cites W2881006593 @default.
- W3167992488 cites W2898066186 @default.
- W3167992488 cites W2944257378 @default.
- W3167992488 cites W2950945243 @default.
- W3167992488 cites W2986691533 @default.
- W3167992488 cites W4255712601 @default.
- W3167992488 doi "https://doi.org/10.3389/fphar.2021.655531" @default.
- W3167992488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8529232" @default.
- W3167992488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34690790" @default.
- W3167992488 hasPublicationYear "2021" @default.
- W3167992488 type Work @default.
- W3167992488 sameAs 3167992488 @default.
- W3167992488 citedByCount "2" @default.
- W3167992488 countsByYear W31679924882021 @default.
- W3167992488 crossrefType "journal-article" @default.
- W3167992488 hasAuthorship W3167992488A5004190418 @default.
- W3167992488 hasAuthorship W3167992488A5007362555 @default.
- W3167992488 hasAuthorship W3167992488A5018256092 @default.
- W3167992488 hasAuthorship W3167992488A5019002683 @default.
- W3167992488 hasAuthorship W3167992488A5028564856 @default.
- W3167992488 hasAuthorship W3167992488A5029231785 @default.
- W3167992488 hasAuthorship W3167992488A5033097552 @default.
- W3167992488 hasAuthorship W3167992488A5045423783 @default.
- W3167992488 hasAuthorship W3167992488A5054977436 @default.
- W3167992488 hasAuthorship W3167992488A5069771802 @default.
- W3167992488 hasAuthorship W3167992488A5074160086 @default.
- W3167992488 hasAuthorship W3167992488A5077142060 @default.
- W3167992488 hasAuthorship W3167992488A5079563573 @default.
- W3167992488 hasAuthorship W3167992488A5079974739 @default.
- W3167992488 hasAuthorship W3167992488A5088563107 @default.
- W3167992488 hasAuthorship W3167992488A5089792184 @default.
- W3167992488 hasBestOaLocation W31679924881 @default.
- W3167992488 hasConcept C126322002 @default.